Secretin family (Class B) G protein-coupled receptors - From molecular to clinical perspectives

British Journal of Pharmacology

Volumn 166, Issue 1, 2012, Pages 1-3

  Poyner, David R ^a   Hay, Debbie L ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

CGRP; family B; G protein coupled receptor; GPCR; secretin

Indexed keywords

AMYLIN RECEPTOR; CALCITONIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; SECRETIN;

CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG DESIGN; DRUG TARGETING; LIGAND BINDING; MOLECULAR DYNAMICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; STRUCTURE ACTIVITY RELATION;

DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 84859705032     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01810.x     Document Type: Review

References (31)

1. Archbold JK, Flanagan JU, Watkins HA, Gingell JJ, Hay DL, (2011). Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends Pharmacol Sci 32: 591-600.
2. Axelsen L, Keung W, Pedersen H, Meier E, Riber D, Kjolbye A, et al,. (2012). Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts. Br J Pharmacol 165: 2736-2748.
3. Bailey RJ, Walker CS, Ferner AH, Loomes KM, Prijic G, Halim A, et al,. (2012). Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes. Br J Pharmacol 166: 151-167.
4. Barwell J, Gingell JJ, Watkins HA, Archbold JK, Poyner DR, Hay DL, (2012). Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br J Pharmacol 166: 51-65.
5. Couvineau A, Laburthe M, (2012). VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins. Br J Pharmacol 166: 42-50.
6. Donnelly D, (2012). The structure and function of the glucagon-like peptide-1 receptor and its ligands. Br J Pharmacol 166: 27-41.
7. Dunworth WP, Caron KM, (2009). G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases. Arterioscler Thromb Vasc Biol 29: 650-656.
8. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB, (2003). The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63: 1256-1272.
9. Furness SGB, Wootten D, Christopoulos A, Sexton PM, (2012). Consequences of splice variation on Secretin family G protein-coupled receptor function. Br J Pharmacol 166: 98-109.
10. Gesty-Palmer D, Luttrell LM, (2011). 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? Br J Pharmacol 164: 59-67.
11. de Graaf C, Rein C, Piwnica D, Giordanetto F, Rognan D, (2011). Structure-based discovery of allosteric modulators of two related class B G-protein-coupled receptors. ChemMedChem 6: 2159-2169.
12. Grace CR, Perrin MH, DiGruccio MR, Miller CL, Rivier JE, Vale WW, et al,. (2004). NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. Proc Natl Acad Sci U S A 101: 12836-12841.
13. Grace CR, Perrin MH, Gulyas J, Rivier JE, Vale WW, Riek R, (2010). NMR structure of the first extracellular domain of corticotropin-releasing factor receptor 1 (ECD1-CRF-R1) complexed with a high affinity agonist. J Biol Chem 285: 38580-38589.
14. Grammatopoulos DK, (2012). Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharmacol 166: 85-97.
15. ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, et al,. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 1083-1093.
16. Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, et al,. (2012). Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1. Br J Pharmacol 166: 4-17.
17. Hay DL, Poyner DR, Sexton PM, (2006). GPCR modulation by RAMPs. Pharmacol Ther 109: 173-197.
18. Hong Y, Hay DL, Quirion R, Poyner DR, (2012). The pharmacology of Adrenomedullin 2/Intermedin. Br J Pharmacol 166: 110-120.
19. Kadmiel M, Fritz-Six K, Pacharne S, Richards GO, Li M, Skerry TM, et al,. (2011). Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol Endocrinol 25: 1244-1253.
20. Karteris E, Markovic D, Chen J, Hillhouse EW, Grammatopoulos DK, (2010). Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone. Endocrinology 151: 4959-4968.
21. Katritch V, Cherezov V, Stevens RC, (2011). Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci 33: 17-27.
22. Kusano S, Kukimoto-Niino M, Hino N, Ohsawa N, Okuda KI, Sakamoto K, et al,. (2011). Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding. Protein Sci. doi: 10.1002/pro.2003.
23. Kuwasako K, Hay DL, Nagata K, Hikosaka T, Kitamura K, Kato J, (2012). The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling. Br J Pharmacol 166: 137-150.
24. 1 receptor. Br J Pharmacol 166: 79-84.
25. Miller LJ, Dong M, Harikumar KG, (2012). Ligand binding and activation of the secretin receptor, a prototypic family B G protein-coupled receptor. Br J Pharmacol 166: 18-26.
26. Moore EL, Salvatore CA, (2012). Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine. Br J Pharmacol 166: 66-78.
27. Pal K, Swaminathan K, Xu HE, Pioszak AA, (2010). Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptor. J Biol Chem 285: 40351-40361.
28. Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D, et al,. (2007). Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci U S A 104: 13942-13947.
29. Pioszak AA, Xu HE, (2008). Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci U S A 105: 5034-5039.
30. Roth JD, Erickson MR, Chen S, Parkes DG, (2012). GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities. Br J Pharmacol 166: 121-136.
31. Runge S, Thogersen H, Madsen K, Lau J, Rudolph R, (2008). Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283: 11340-11347.